Endometriosis Trial, Recruiting NCT06510647 Sponsor: University of Cagliari Condition: Endometriosis
Back to Endometriosis

Endometriosis Trial, Recruiting

NCT06510647
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 50 years old
  • You have painful symptoms linked to endometriosis — such as pain during sex, pain when having a bowel movement, painful periods, ongoing pelvic pain, pain when urinating, or pain around the time of ovulation — and at least one of these pains rates higher than 5 out of 10 on a pain scale
  • Your doctor has recommended that you take a hormone-based pill (taken by mouth) to treat your endometriosis
  • You are willing and able to give your informed consent to take part in the trial

Who may not be able to join:

  • You have a medical reason why you cannot take oral (by mouth) hormone therapy
  • You currently have, or have had in the past, an infection in your pelvic area
  • You have a history of cancer, or there is currently a concern that you may have a cancerous growth in your reproductive system
  • You have had previous pelvic surgery, such as removal of the womb, fallopian tubes, ovarian cysts, fibroids, surgery for endometriosis, or bowel surgery
  • You have another known condition that causes long-term pelvic pain (confirm with trial site)
  • You have already gone through menopause

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 07051093399

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Cagliari
Registry
ClinicalTrials.gov
Start date
26 February 2024
Est. completion
1 July 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Percentage of patients with endometriosis who are non-responsive to medical therapy after 12 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov